Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000611089 | SCV000710967 | uncertain significance | not specified | 2016-05-27 | criteria provided, single submitter | clinical testing | The p.Glu4462Lys variant in TTN has not been previously reported in individuals with cardiomyopathy, but has been identified in 6/6768 African chromosomes by th e Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs37 6593556). Computational prediction tools and conservation analysis do not provid e strong support for or against an impact to the protein. In summary, the clinic al significance of the p.Glu4462Lys variant is uncertain. |
Invitae | RCV000643455 | SCV000765142 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-12-28 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000727862 | SCV000855330 | uncertain significance | not provided | 2017-11-09 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000611089 | SCV001519476 | likely benign | not specified | 2021-03-15 | criteria provided, single submitter | clinical testing | Variant summary: TTN c.13384G>A (p.Glu4462Lys) results in a conservative amino acid change located in the I-band domain of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 4.6e-05 in 279748 control chromosomes, predominantly at a frequency of 0.0005 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 1.3 fold of the estimated maximal expected allele frequency for a pathogenic variant in TTN causing Dilated Cardiomyopathy phenotype (0.00039), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no occurrence of c.13384G>A in individuals affected with Dilated Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. Three ClinVar submitters (evaluation after 2014) cite the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely benign. |
Gene |
RCV000727862 | SCV001778465 | likely benign | not provided | 2019-06-06 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000727862 | SCV003820160 | uncertain significance | not provided | 2021-05-26 | criteria provided, single submitter | clinical testing |